Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Active U.S. Real Estate Powershares | PSR | Oct 18, 2024 | 98.86 | +0.78 |
Actuate Therapeutics | ACTU | Oct 18, 2024 | 7.26 | 0.00 |
Acuity Brands | AYI | Oct 18, 2024 | 307.55 | +0.32 |
Acumen Pharmaceuticals | ABOS | Oct 18, 2024 | 2.86 | +7.52 |
Acurx Pharmaceuticals | ACXP | Oct 18, 2024 | 2.01 | -0.50 |
Acushnet | GOLF | Oct 18, 2024 | 62.30 | -3.46 |
ACV Auctions A | ACVA | Oct 18, 2024 | 19.05 | -0.78 |
ACWI Ex-US Index MSCI Ishares | ACWX | Oct 18, 2024 | 56.40 | +0.75 |
ACWI Index MSCI Ishares | ACWI | Oct 18, 2024 | 120.65 | +0.58 |
Adagene ADR | ADAG | Oct 18, 2024 | 2.61 | +8.30 |
Adagio Medical | ADGM | Oct 18, 2024 | 2.80 | 0.00 |
Adams Diversified Equity Fund | ADX | Oct 18, 2024 | 21.92 | +0.27 |
Adams Natural Resources Fund | PEO | Oct 18, 2024 | 23.99 | +0.13 |
Adams Resources & Energy | AE | Oct 18, 2024 | 26.25 | -1.06 |
AdaptHealth | AHCO | Oct 18, 2024 | 11.00 | +1.57 |
Adaptimmune Therapeutics ADR | ADAP | Oct 18, 2024 | 0.84 | +0.14 |
Adaptive Biotechnologies | ADPT | Oct 18, 2024 | 4.68 | +0.86 |
ADC Therapeutics SA | ADCT | Oct 18, 2024 | 3.12 | -0.64 |
Addentax Group | ATXG | Oct 18, 2024 | 0.70 | +0.72 |
Addex Therapeutics ADR | ADXN | Oct 18, 2024 | 10.44 | -1.51 |
Addus HomeCare | ADUS | Oct 18, 2024 | 131.81 | -0.90 |
Adecoagro | AGRO | Oct 18, 2024 | 11.38 | -0.09 |
Adeia | ADEA | Oct 18, 2024 | 12.44 | -0.24 |
Adial Pharmaceuticals | ADIL | Oct 18, 2024 | 1.01 | +4.11 |
Adicet Bio | ACET | Oct 18, 2024 | 1.45 | -2.03 |
Adient | ADNT | Oct 18, 2024 | 22.75 | +4.21 |
Aditxt | ADTX | Oct 18, 2024 | 1.05 | -2.78 |
Adlai Nortye | ANL | Oct 18, 2024 | 1.95 | 0.00 |
ADMA Biologics | ADMA | Oct 18, 2024 | 15.78 | -2.11 |
Adobe | ADBE | Oct 18, 2024 | 494.90 | -0.39 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.